{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:32:09Z","timestamp":1791232329692,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11102-024-01442-8","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T03:02:02Z","timestamp":1725591722000},"page":"955-969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Long COVID and pituitary dysfunctions: a bidirectional relationship?"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6117-0081","authenticated-orcid":false,"given":"Luigi","family":"di Filippo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Doga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"1442_CR1","unstructured":"COVID-19 cases | WHO COVID-19 dashboard Accessed: Jul. 09, 2024. [Online]. Available: https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c"},{"key":"1442_CR2","doi-asserted-by":"publisher","unstructured":"Gupta A et al (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26(7):1017\u20131032. https:\/\/doi.org\/10.1038\/S41591-020-0968-3","DOI":"10.1038\/S41591-020-0968-3"},{"key":"1442_CR3","doi-asserted-by":"publisher","unstructured":"Giustina A, Bilezikian JP (2022) Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic. Rev Endocr Metab Disord 23(2):133\u2013136. https:\/\/doi.org\/10.1007\/S11154-022-09716-X","DOI":"10.1007\/S11154-022-09716-X"},{"key":"1442_CR4","doi-asserted-by":"publisher","unstructured":"Puig-Domingo M, Marazuela M, Yildiz BO, Giustina A (2021) COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. Endocrine 72(2):301\u2013316. https:\/\/doi.org\/10.1007\/S12020-021-02734-W","DOI":"10.1007\/S12020-021-02734-W"},{"key":"1442_CR5","doi-asserted-by":"publisher","unstructured":"Marazuela M, Giustina A, Puig-Domingo M (2020) Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord 21(4):495\u2013507. https:\/\/doi.org\/10.1007\/S11154-020-09569-2","DOI":"10.1007\/S11154-020-09569-2"},{"key":"1442_CR6","doi-asserted-by":"publisher","unstructured":"Puig-Domingo M, Marazuela M, Giustina A (2020) COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 68(1):2\u20135. https:\/\/doi.org\/10.1007\/S12020-020-02294-5","DOI":"10.1007\/S12020-020-02294-5"},{"key":"1442_CR7","doi-asserted-by":"publisher","unstructured":"De Lorenzo R et al (2023) Longitudinal changes in physical function and their impact on Health outcomes in COVID-19 patients. Nutrients 15(20). https:\/\/doi.org\/10.3390\/NU15204474","DOI":"10.3390\/NU15204474"},{"key":"1442_CR8","doi-asserted-by":"publisher","unstructured":"di Filippo L, Frara S, Doga M, Giustina A (2022) The osteo-metabolic phenotype of COVID-19: an update. Endocrine 78(2):247\u2013254. https:\/\/doi.org\/10.1007\/S12020-022-03135-3","DOI":"10.1007\/S12020-022-03135-3"},{"key":"1442_CR9","doi-asserted-by":"publisher","unstructured":"di Filippo L et al (2022) Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors. Endocrine 77(2):392\u2013400. https:\/\/doi.org\/10.1007\/S12020-022-03096-7","DOI":"10.1007\/S12020-022-03096-7"},{"key":"1442_CR10","doi-asserted-by":"publisher","unstructured":"di Filippo L et al (2021) Hypocalcemia in COVID-19 is associated with low vitamin D levels and impaired compensatory PTH response. Endocrine 74(2):219\u2013225. https:\/\/doi.org\/10.1007\/S12020-021-02882-Z","DOI":"10.1007\/S12020-021-02882-Z"},{"key":"1442_CR11","doi-asserted-by":"publisher","unstructured":"di Filippo L, Frara S, Giustina A (2021) The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects. Nat Rev Endocrinol 17(8):445\u2013446. https:\/\/doi.org\/10.1038\/S41574-021-00516-Y","DOI":"10.1038\/S41574-021-00516-Y"},{"key":"1442_CR12","doi-asserted-by":"publisher","unstructured":"di Filippo L, Doga M, Frara S, Giustina A (2022) Hypocalcemia in COVID-19: prevalence, clinical significance and therapeutic implications. Rev Endocr Metab Disord 23(2):299\u2013308. https:\/\/doi.org\/10.1007\/S11154-021-09655-Z","DOI":"10.1007\/S11154-021-09655-Z"},{"key":"1442_CR13","doi-asserted-by":"publisher","unstructured":"di Filippo L et al (2021) Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients. Endocrine 71(1):9\u201313. https:\/\/doi.org\/10.1007\/S12020-020-02541-9","DOI":"10.1007\/S12020-020-02541-9"},{"key":"1442_CR14","doi-asserted-by":"publisher","unstructured":"Di Filippo L, Formenti AM, Doga M, Pedone E, Rovere-Querini P, Giustina A (2021) Radiological thoracic vertebral fractures are highly prevalent in COVID-19 and predict Disease outcomes. J Clin Endocrinol Metab 106(2):E602\u2013E614. https:\/\/doi.org\/10.1210\/CLINEM\/DGAA738","DOI":"10.1210\/CLINEM\/DGAA738"},{"key":"1442_CR15","doi-asserted-by":"publisher","unstructured":"di Filippo L, Formenti AM, Giustina A (2020) Hypocalcemia: the quest for the cause of a major biochemical feature of COVID-19. Endocrine 70(3):463\u2013464. https:\/\/doi.org\/10.1007\/S12020-020-02525-9","DOI":"10.1007\/S12020-020-02525-9"},{"key":"1442_CR16","doi-asserted-by":"publisher","unstructured":"Di Filippo L et al (2020) Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Endocrine 68(3):475\u2013478. https:\/\/doi.org\/10.1007\/S12020-020-02383-5","DOI":"10.1007\/S12020-020-02383-5"},{"key":"1442_CR17","doi-asserted-by":"publisher","unstructured":"Frara S, Allora A, Castellino L, di Filippo L, Loli P, Giustina A (2021) COVID-19 and the pituitary. Pituitary 24(3):465\u2013481. https:\/\/doi.org\/10.1007\/S11102-021-01148-1","DOI":"10.1007\/S11102-021-01148-1"},{"key":"1442_CR18","doi-asserted-by":"publisher","unstructured":"Frara S et al (2022) COVID-19 and hypopituitarism. Rev Endocr Metab Disord 23(2):215\u2013231. https:\/\/doi.org\/10.1007\/S11154-021-09672-Y","DOI":"10.1007\/S11154-021-09672-Y"},{"key":"1442_CR19","doi-asserted-by":"publisher","unstructured":"Giustina A, Legg E, Cesana BM, Frara S, Mortini P, Fleseriu M (2021) Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era. Endocrine 71(2):273\u2013280. https:\/\/doi.org\/10.1007\/S12020-020-02565-1","DOI":"10.1007\/S12020-020-02565-1"},{"key":"1442_CR20","doi-asserted-by":"publisher","unstructured":"Capatina C, Poiana C, Fleseriu M (2023) Pituitary and SARS CoV-2: an unremitting conundrum. Best Pract Res Clin Endocrinol Metab 37(4). https:\/\/doi.org\/10.1016\/J.BEEM.2023.101752","DOI":"10.1016\/J.BEEM.2023.101752"},{"key":"1442_CR21","doi-asserted-by":"publisher","unstructured":"Han T, Kang J, Li G, Ge J, Gu J (2020) Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study. Ann Transl Med 8(17):1077. https:\/\/doi.org\/10.21037\/ATM-20-4281","DOI":"10.21037\/ATM-20-4281"},{"key":"1442_CR22","doi-asserted-by":"publisher","unstructured":"Ding Y et al (2004) Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 203(2):622\u2013630. https:\/\/doi.org\/10.1002\/PATH.1560","DOI":"10.1002\/PATH.1560"},{"key":"1442_CR23","doi-asserted-by":"publisher","unstructured":"Khadke S et al (2020) Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents. Virol J 17(1). https:\/\/doi.org\/10.1186\/S12985-020-01415-W","DOI":"10.1186\/S12985-020-01415-W"},{"key":"1442_CR24","doi-asserted-by":"publisher","unstructured":"Azkur AK et al (2020) Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy 75(7):1564\u20131581. https:\/\/doi.org\/10.1111\/ALL.14364","DOI":"10.1111\/ALL.14364"},{"key":"1442_CR25","doi-asserted-by":"publisher","unstructured":"Troshina E, Melnichenko G, Senyushkina E, Mokrysheva N (2020) Adaptation of the hypothalamo-pituitary-thyroid and hypothalamo-pituitary-adrenal systems to a new infectious disease - COVID-19 in the development of COVID-19 pneumonia and\/or cytokine storm. Clin Exp Thyroidol 16(1):21\u201327. https:\/\/doi.org\/10.14341\/KET12461","DOI":"10.14341\/KET12461"},{"key":"1442_CR26","doi-asserted-by":"publisher","unstructured":"Bonetto V et al (2022) Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol 13. https:\/\/doi.org\/10.3389\/FIMMU.2022.1070379","DOI":"10.3389\/FIMMU.2022.1070379"},{"key":"1442_CR27","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-De-las-pe\u00f1as C, Palacios-Ce\u00f1a D, G\u00f3mez-Mayordomo V, Cuadrado ML, Florencio LL (2021) Defining post-COVID symptoms (post-, acute COVID, long COVID Persistent Post-COVID): an integrative classification. Int J Environ Res Public Health 18(5):1\u20139. https:\/\/doi.org\/10.3390\/IJERPH18052621","DOI":"10.3390\/IJERPH18052621"},{"key":"1442_CR28","doi-asserted-by":"publisher","unstructured":"Sivan M, Taylor S (2020) NICE guideline on long covid. BMJ 371. https:\/\/doi.org\/10.1136\/BMJ.M4938","DOI":"10.1136\/BMJ.M4938"},{"key":"1442_CR29","unstructured":"Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE [Online]. https:\/\/www.nice.org.uk\/guidance\/ng188. Accessed 09 Jul 2024"},{"key":"1442_CR30","doi-asserted-by":"publisher","unstructured":"Notarte KI et al (2022) Age, sex and previous comorbidities as risk factors not Associated with SARS-CoV-2 infection for long COVID-19: a systematic review and Meta-analysis. J Clin Med 11(24). https:\/\/doi.org\/10.3390\/JCM11247314","DOI":"10.3390\/JCM11247314"},{"key":"1442_CR31","doi-asserted-by":"publisher","unstructured":"Maglietta G et al (2022) Prognostic factors for Post-COVID-19 syndrome: a systematic review and Meta-analysis. J Clin Med 11(6). https:\/\/doi.org\/10.3390\/JCM11061541\/S1","DOI":"10.3390\/JCM11061541\/S1"},{"issue":"4","key":"1442_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.24875\/AIDSREV.22000025","volume":"24","author":"I Pintos-Pascual","year":"2022","unstructured":"Pintos-Pascual I et al (2022) Is SARS-CoV-2 the only cause of long-COVID? AIDS Rev 24(4):183\u2013196. https:\/\/doi.org\/10.24875\/AIDSREV.22000025","journal-title":"AIDS Rev"},{"key":"1442_CR33","doi-asserted-by":"publisher","unstructured":"Boaventura P, Macedo S, Ribeiro F, Jaconiano S, Soares P (2022) Post-COVID-19 condition: where are we now? Life (Basel) 12(4). https:\/\/doi.org\/10.3390\/LIFE12040517","DOI":"10.3390\/LIFE12040517"},{"key":"1442_CR34","doi-asserted-by":"publisher","unstructured":"Giustina A (2021) Hypovitaminosis D and the endocrine phenotype of COVID-19. Endocrine 72(1). https:\/\/doi.org\/10.1007\/S12020-021-02671-8","DOI":"10.1007\/S12020-021-02671-8"},{"key":"1442_CR35","doi-asserted-by":"publisher","unstructured":"Bilezikian JP et al (2020) Mechanisms in endocrinology: vitamin D and COVID-19. Eur J Endocrinol 183(5):R133\u2013R147. https:\/\/doi.org\/10.1530\/EJE-20-0665","DOI":"10.1530\/EJE-20-0665"},{"key":"1442_CR36","doi-asserted-by":"publisher","DOI":"10.1210\/ENDREV\/BNAE009","author":"A Giustina","year":"2024","unstructured":"Giustina A et al (2024) Consensus statement on vitamin D status assessment and supplementation: whys, whens, and hows. Endocr Rev. https:\/\/doi.org\/10.1210\/ENDREV\/BNAE009","journal-title":"Endocr Rev Apr"},{"key":"1442_CR37","doi-asserted-by":"publisher","unstructured":"Di Filippo L et al (2022) Vitamin D levels are associated with blood glucose and BMI in COVID-19 patients, predicting disease severity. J Clin Endocrinol Metab 107(1):E348\u2013E360. https:\/\/doi.org\/10.1210\/CLINEM\/DGAB599","DOI":"10.1210\/CLINEM\/DGAB599"},{"key":"1442_CR38","doi-asserted-by":"publisher","unstructured":"di Filippo L, Uygur M, Locatelli M, Nannipieri F, Frara S, Giustina A (2023) Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization. Endocrine 80(3):669\u2013683. https:\/\/doi.org\/10.1007\/S12020-023-03331-9","DOI":"10.1007\/S12020-023-03331-9"},{"key":"1442_CR39","doi-asserted-by":"publisher","unstructured":"Bilezikian JP et al (2023) Consensus and controversial aspects of vitamin D and COVID-19. J Clin Endocrinol Metab 108(5):1034\u20131042. https:\/\/doi.org\/10.1210\/CLINEM\/DGAC719","DOI":"10.1210\/CLINEM\/DGAC719"},{"key":"1442_CR40","doi-asserted-by":"publisher","unstructured":"di Filippo L (2023) Lack of vitamin D predicts impaired long-term immune response to COVID-19 vaccination. Endocrine 82(3):536\u2013541. https:\/\/doi.org\/10.1007\/S12020-023-03481-W","DOI":"10.1007\/S12020-023-03481-W"},{"key":"1442_CR41","doi-asserted-by":"publisher","unstructured":"di Filippo L et al (2023) Low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors. J Clin Endocrinol Metab 108(10):e1106\u2013e1116. https:\/\/doi.org\/10.1210\/CLINEM\/DGAD207","DOI":"10.1210\/CLINEM\/DGAD207"},{"key":"1442_CR42","doi-asserted-by":"publisher","unstructured":"di Filippo L, Frara S, Giustina A (2023) Response to the letter to the editor from Min et al: low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors. J Clin Endocrinol Metab 109(1):E438\u2013E439. https:\/\/doi.org\/10.1210\/CLINEM\/DGAD327","DOI":"10.1210\/CLINEM\/DGAD327"},{"key":"1442_CR43","doi-asserted-by":"publisher","unstructured":"Townsend L et al (2020) Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE 15(11). https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0240784","DOI":"10.1371\/JOURNAL.PONE.0240784"},{"key":"1442_CR44","doi-asserted-by":"publisher","unstructured":"Isidori AM, Minnetti M, Sbardella E, Graziadio C, Grossman AB (2015) Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect. Eur J Endocrinol 173(3):R101\u2013R113. https:\/\/doi.org\/10.1530\/EJE-15-0308","DOI":"10.1530\/EJE-15-0308"},{"key":"1442_CR45","doi-asserted-by":"publisher","unstructured":"Chiovato L, Magri F, Carl\u00e9 A (2019) Hypothyroidism in context: where we\u2019ve been and where we\u2019re going. Adv Ther 36(Suppl 2):47\u201358. https:\/\/doi.org\/10.1007\/S12325-019-01080-8","DOI":"10.1007\/S12325-019-01080-8"},{"key":"1442_CR46","doi-asserted-by":"publisher","unstructured":"Doga M, Bonadonna S, Gola M, Mazziotti G, Giustina A (2006) Growth hormone deficiency in the adult. Pituitary 9(4):305\u2013311. https:\/\/doi.org\/10.1007\/S11102-006-0410-Y","DOI":"10.1007\/S11102-006-0410-Y"},{"key":"1442_CR47","doi-asserted-by":"publisher","unstructured":"Hampshire A et al (2021) Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine 39. https:\/\/doi.org\/10.1016\/J.ECLINM.2021.101044","DOI":"10.1016\/J.ECLINM.2021.101044"},{"key":"1442_CR48","doi-asserted-by":"publisher","unstructured":"Su Y et al (2022) Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185(5):881\u2013895. https:\/\/doi.org\/10.1016\/J.CELL.2022.01.014","DOI":"10.1016\/J.CELL.2022.01.014"},{"key":"1442_CR49","doi-asserted-by":"publisher","unstructured":"Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8(5):416\u2013427. https:\/\/doi.org\/10.1016\/S2215-0366(21)00084-5","DOI":"10.1016\/S2215-0366(21)00084-5"},{"key":"1442_CR50","doi-asserted-by":"publisher","unstructured":"Moreno-Perez O et al (2022) Male pituitary-gonadal axis dysfunction in post-acute COVID-19 syndrome-Prevalence and associated factors: a mediterranean case series. Clin Endocrinol (Oxf) 96(3):353\u2013362. https:\/\/doi.org\/10.1111\/CEN.14537","DOI":"10.1111\/CEN.14537"},{"key":"1442_CR51","doi-asserted-by":"publisher","unstructured":"Salonia A et al (2022) Testosterone in males with COVID-19: a 7-month cohort study. Andrology 10(1):34\u201341. https:\/\/doi.org\/10.1111\/ANDR.13097","DOI":"10.1111\/ANDR.13097"},{"key":"1442_CR52","doi-asserted-by":"publisher","unstructured":"Chiloiro S et al (2019) The changing clinical spectrum of Hypophysitis. Trends Endocrinol Metab 30(9):590\u2013602. https:\/\/doi.org\/10.1016\/J.TEM.2019.06.004","DOI":"10.1016\/J.TEM.2019.06.004"},{"key":"1442_CR53","doi-asserted-by":"publisher","unstructured":"Mazziotti G, et al (2017) Management of endocrine disease: risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects. Eur J Endocrinol 177(5):R231\u2013R248. https:\/\/doi.org\/10.1530\/EJE-17-0154","DOI":"10.1530\/EJE-17-0154"},{"key":"1442_CR54","doi-asserted-by":"publisher","unstructured":"Leow MKS, Kwek DSK, Ng AWK, Ong KC, Kaw GJL, Lee LSU (2005) Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) 63(2):197\u2013202. https:\/\/doi.org\/10.1111\/J.1365-2265.2005.02325.X","DOI":"10.1111\/J.1365-2265.2005.02325.X"},{"issue":"5","key":"1442_CR55","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.mehy.2004.04.009","volume":"63","author":"R Wheatland","year":"2004","unstructured":"Wheatland R (2004) Molecular mimicry of ACTH in SARS - implications for corticosteroid treatment and prophylaxis. Med Hypotheses 63(5):855\u2013862. https:\/\/doi.org\/10.1016\/j.mehy.2004.04.009","journal-title":"Med Hypotheses"},{"issue":"4","key":"1442_CR56","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1139\/O10-022","volume":"88","author":"L Wei","year":"2010","unstructured":"Wei L et al (2010) Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS). Biochem Cell Biol 88(4):723\u2013730. https:\/\/doi.org\/10.1139\/O10-022","journal-title":"Biochem Cell Biol"},{"key":"1442_CR57","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Torres D, D\u00edaz-Rodr\u00edguez C, Armentia-Medina A (2022) Anti-ACTH antibodies in critically ill Covid-19 patients: a potential immune evasion mechanism of SARS-CoV-2. Med Intensiva 46(8):472\u2013474. https:\/\/doi.org\/10.1016\/J.MEDINE.2021.09.001","DOI":"10.1016\/J.MEDINE.2021.09.001"},{"key":"1442_CR58","doi-asserted-by":"publisher","unstructured":"Gonen MS et al (2022) Assessment of neuroendocrine changes and hypothalamo-pituitary autoimmunity in patients with COVID-19. Horm Metab Res 54(3):153\u2013161. https:\/\/doi.org\/10.1055\/A-1764-1260","DOI":"10.1055\/A-1764-1260"},{"key":"1442_CR59","doi-asserted-by":"publisher","unstructured":"Taieb A, Nassim BHS, Asma G, Jabeur M, Ghada S, Asma BA (2024) The Growing understanding of the pituitary implication in the pathogenesis of long COVID-19 syndrome: a narrative review. Adv Respir Med 92(1):96\u2013109. https:\/\/doi.org\/10.3390\/ARM92010013","DOI":"10.3390\/ARM92010013"},{"key":"1442_CR60","doi-asserted-by":"publisher","unstructured":"Clarke SA et al (2021) Normal adrenal and thyroid function in patients who survive COVID-19 infection. J Clin Endocrinol Metab 106(8):2208\u20132220. https:\/\/doi.org\/10.1210\/CLINEM\/DGAB349","DOI":"10.1210\/CLINEM\/DGAB349"},{"issue":"6","key":"1442_CR61","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1507\/ENDOCRJ.EJ21-0531","volume":"69","author":"E Urhan","year":"2022","unstructured":"Urhan E, Karaca Z, Unuvar GK, Gundogan K, Unluhizarci K (2022) Investigation of pituitary functions after acute coronavirus disease 2019. Endocr J 69(6):649\u2013658. https:\/\/doi.org\/10.1507\/ENDOCRJ.EJ21-0531","journal-title":"Endocr J"},{"key":"1442_CR62","doi-asserted-by":"publisher","unstructured":"Ramesh J (2023) Evaluation of the hypothalamo-pituitary-adrenal axis during the post-COVID-19 period in patients treated with steroids during the illness. Arch Endocrinol Metab 68:e220207. https:\/\/doi.org\/10.20945\/2359-4292-2022-0207","DOI":"10.20945\/2359-4292-2022-0207"},{"issue":"4","key":"1442_CR63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/07435800.2023.2245907","volume":"48","author":"KG Rashmi","year":"2023","unstructured":"Rashmi KG et al (2023) Hypothalamic-pituitary adrenal Axis Status 3 months after recovery from COVID-19 infection. Endocr Res 48(4):85\u201393. https:\/\/doi.org\/10.1080\/07435800.2023.2245907","journal-title":"Endocr Res"},{"key":"1442_CR64","doi-asserted-by":"publisher","unstructured":"Klein J et al (2023) Distinguishing features of long COVID identified through immune profiling. Nature 623(7985):139\u2013148. https:\/\/doi.org\/10.1038\/S41586-023-06651-Y","DOI":"10.1038\/S41586-023-06651-Y"},{"key":"1442_CR65","doi-asserted-by":"publisher","unstructured":"Ach T et al (2024) Explaining long COVID: a pioneer cross-sectional study supporting the endocrine hypothesis. J Endocr Soc 8(3). https:\/\/doi.org\/10.1210\/JENDSO\/BVAE003","DOI":"10.1210\/JENDSO\/BVAE003"},{"issue":"1","key":"1442_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/EDRV-5-1-1","volume":"5","author":"ME Keller-Wood","year":"1984","unstructured":"Keller-Wood ME, Dallman MF (1984) Corticosteroid inhibition of ACTH secretion. Endocr Rev 5(1):1\u201324. https:\/\/doi.org\/10.1210\/EDRV-5-1-1","journal-title":"Endocr Rev"},{"key":"1442_CR67","doi-asserted-by":"publisher","unstructured":"Shipston MJ (2022) Glucocorticoid action in the anterior pituitary gland: insights from corticotroph physiology. Curr Opin Endocr Metab Res 25. https:\/\/doi.org\/10.1016\/J.COEMR.2022.100358","DOI":"10.1016\/J.COEMR.2022.100358"},{"key":"1442_CR68","doi-asserted-by":"publisher","unstructured":"Quaranta VN et al (2023) The predictors of long COVID in Southeastern Italy. J Clin Med 12(19). https:\/\/doi.org\/10.3390\/JCM12196303","DOI":"10.3390\/JCM12196303"},{"key":"1442_CR69","doi-asserted-by":"publisher","unstructured":"Davelaar J, Jessurun N, Schaap G, Bode C, Vonkeman H (2023) The effect of corticosteroids, antibiotics, and anticoagulants on the development of post-COVID-19 syndrome in COVID-19 hospitalized patients 6 months after discharge: a retrospective follow up study, Clin Exp Med 23(8):4881\u20134888. https:\/\/doi.org\/10.1007\/S10238-023-01153-7","DOI":"10.1007\/S10238-023-01153-7"},{"key":"1442_CR70","doi-asserted-by":"publisher","unstructured":"Beuschlein F (2024) European Society of Endocrinology and Endocrine Society Joint Clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. J Clin Endocrinol Metab 109(7):1657\u20131683. https:\/\/doi.org\/10.1210\/CLINEM\/DGAE250","DOI":"10.1210\/CLINEM\/DGAE250"},{"key":"1442_CR71","doi-asserted-by":"publisher","unstructured":"Zou R et al (2020) Euthyroid sick syndrome in patients with COVID-19. Front Endocrinol (Lausanne) 11. https:\/\/doi.org\/10.3389\/FENDO.2020.566439","DOI":"10.3389\/FENDO.2020.566439"},{"key":"1442_CR72","doi-asserted-by":"publisher","unstructured":"Brancatella A, Viola N, Santini F, Latrofa F (2023) COVID-induced thyroid autoimmunity. Best Pract Res Clin Endocrinol Metab 37(2). https:\/\/doi.org\/10.1016\/J.BEEM.2023.101742","DOI":"10.1016\/J.BEEM.2023.101742"},{"key":"1442_CR73","doi-asserted-by":"publisher","unstructured":"Meftah E et al (2023) Subacute thyroiditis following COVID-19: a systematic review. Front Endocrinol (Lausanne) 14. https:\/\/doi.org\/10.3389\/FENDO.2023.1126637","DOI":"10.3389\/FENDO.2023.1126637"},{"key":"1442_CR74","doi-asserted-by":"publisher","unstructured":"Baldelli R et al (2021) Thyroid dysfunction in COVID-19 patients. J Endocrinol Invest 44(12):2735\u20132739. https:\/\/doi.org\/10.1007\/S40618-021-01599-0","DOI":"10.1007\/S40618-021-01599-0"},{"key":"1442_CR75","doi-asserted-by":"publisher","unstructured":"Khoo B, et al (2021) Thyroid function before, during, and, after COVID-19. J Clin Endocrinol Metab 106(2):E803\u2013E811. https:\/\/doi.org\/10.1210\/CLINEM\/DGAA830","DOI":"10.1210\/CLINEM\/DGAA830"},{"key":"1442_CR76","doi-asserted-by":"publisher","unstructured":"Lui DTW et al (2021) Long COVID in patients with mild to moderate disease: do thyroid function and autoimmunity play a role? Endocr Pract 27(9):894\u2013902. https:\/\/doi.org\/10.1016\/J.EPRAC.2021.06.016","DOI":"10.1016\/J.EPRAC.2021.06.016"},{"key":"1442_CR77","doi-asserted-by":"publisher","unstructured":"Lui DTW et al (2023) A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors. Endocrine 80(2):380\u2013391. https:\/\/doi.org\/10.1007\/S12020-022-03281-8","DOI":"10.1007\/S12020-022-03281-8"},{"key":"1442_CR78","doi-asserted-by":"publisher","unstructured":"Facondo P et al (2022) Case report: hypothalamic amenorrhea following COVID-19 infection and review of literatures. Front Endocrinol (Lausanne) 13. https:\/\/doi.org\/10.3389\/FENDO.2022.840749","DOI":"10.3389\/FENDO.2022.840749"},{"issue":"2","key":"1442_CR79","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0300-9084(89)90066-7","volume":"71","author":"G Brabant","year":"1989","unstructured":"Brabant G, Ocran K, Ranft U, Von Zur A, M\u00fchlen, Hesch RD (1989) Physiological regulation of thyrotropin. Biochimie 71(2):293\u2013301. https:\/\/doi.org\/10.1016\/0300-9084(89)90066-7","journal-title":"Biochimie"},{"key":"1442_CR80","doi-asserted-by":"publisher","unstructured":"Yu P, Yuan H, Chen H, Li X (2024) Thyroid function spectrum in Cushing\u2019s syndrome. BMC Endocr Disord 24(1). https:\/\/doi.org\/10.1186\/S12902-024-01614-4","DOI":"10.1186\/S12902-024-01614-4"},{"key":"1442_CR81","doi-asserted-by":"publisher","unstructured":"Brandi ML, Giustina A (2020) Sexual dimorphism of coronavirus 19 morbidity and lethality. Trends Endocrinol Metab 31(12):918\u2013927. https:\/\/doi.org\/10.1016\/J.TEM.2020.09.003","DOI":"10.1016\/J.TEM.2020.09.003"},{"key":"1442_CR82","doi-asserted-by":"publisher","unstructured":"Groti Antonic K, Antonic B, Caliber M, Dhindsa S (2024) Men, testosterone and Covid-19. Clin Endocrinol (Oxf) 100(1):56\u201365. https:\/\/doi.org\/10.1111\/CEN.14952","DOI":"10.1111\/CEN.14952"},{"key":"1442_CR83","doi-asserted-by":"publisher","unstructured":"Al-kuraishy HM et al (2023) Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19. Sci Rep 13(1):1. https:\/\/doi.org\/10.1038\/s41598-023-32211-5","DOI":"10.1038\/s41598-023-32211-5"},{"key":"1442_CR84","doi-asserted-by":"publisher","unstructured":"Salonia A et al (2023) Testosterone in males with COVID-19: a 12-month cohort study. Andrology 11(1):17\u201323. https:\/\/doi.org\/10.1111\/ANDR.13322","DOI":"10.1111\/ANDR.13322"},{"key":"1442_CR85","doi-asserted-by":"publisher","unstructured":"Bhasin S et al (2018) Testosterone therapy in men with hypogonadism: an endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 103(5):1715\u20131744. https:\/\/doi.org\/10.1210\/JC.2018-00229","DOI":"10.1210\/JC.2018-00229"},{"issue":"9","key":"1442_CR86","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/BF03349263","volume":"31","author":"A Giustina","year":"2008","unstructured":"Giustina A et al (2008) Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults. J Endocrinol Invest 31(9):820\u2013838. https:\/\/doi.org\/10.1007\/BF03349263","journal-title":"J Endocrinol Invest"},{"key":"1442_CR87","doi-asserted-by":"publisher","unstructured":"Gazzaruso C, Gola M, Karamouzis I, Giubbini R, Giustina A (2014) Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH\u2013an update. J Clin Endocrinol Metab 99(1):18\u201329. https:\/\/doi.org\/10.1210\/JC.2013-2394","DOI":"10.1210\/JC.2013-2394"},{"key":"1442_CR88","doi-asserted-by":"publisher","unstructured":"Gola M, Bonadonna S, Doga M, Giustina A (2005) Clinical review: growth hormone and cardiovascular risk factors. J Clin Endocrinol Metab 90(3):1864\u20131870. https:\/\/doi.org\/10.1210\/JC.2004-0545","DOI":"10.1210\/JC.2004-0545"},{"issue":"10","key":"1442_CR89","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1507\/ENDOCRJ.EJ22-0093","volume":"69","author":"N Sunada","year":"2022","unstructured":"Sunada N et al (2022) Hormonal trends in patients suffering from long COVID symptoms. Endocr J 69(10):1173\u20131181. https:\/\/doi.org\/10.1507\/ENDOCRJ.EJ22-0093","journal-title":"Endocr J"},{"key":"1442_CR90","unstructured":"Study details | brain and gut plasticity in mild TBI or post-acute COVID syndrome following growth hormone therapy | ClinicalTrials.gov. [Online]. https:\/\/clinicaltrials.gov\/study\/NCT03554265. Accessed 10 Jul 2024"},{"key":"1442_CR91","doi-asserted-by":"publisher","unstructured":"Mazziotti G, Giustina A (2013) Glucocorticoids and the regulation of growth hormone secretion. Nat Rev Endocrinol 9(5):265\u2013276. https:\/\/doi.org\/10.1038\/NRENDO.2013.5","DOI":"10.1038\/NRENDO.2013.5"},{"key":"1442_CR92","doi-asserted-by":"publisher","unstructured":"Giustina A, Mazziotti G (2014) Impaired growth hormone secretion associated with low glucocorticoid levels: an experimental model for the Giustina effect. Endocrine 47(2):354\u2013356. https:\/\/doi.org\/10.1007\/S12020-014-0278-Y","DOI":"10.1007\/S12020-014-0278-Y"},{"key":"1442_CR93","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/1043-2760(92)90142-N","volume":"3","author":"A Giustina","year":"1992","unstructured":"Giustina A, Wehrenberg WB (1992) The role of glucocorticoids in the regulation of growth hormone secretion: mechanisms and clinical significance. Trends Endocrinol Metab 3:306\u2013311. https:\/\/doi.org\/10.1016\/1043-2760(92)90142-N","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"1442_CR94","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1210\/JCEM-68-1-120","volume":"68","author":"A Giustina","year":"1989","unstructured":"Giustina A, Romanelli G, Candrina R, Giustina G (1989) Growth hormone deficiency in patients with idiopathic adrenocorticotropin deficiency resolves during glucocorticoid replacement. J Clin Endocrinol Metab 68(1):120\u2013124. https:\/\/doi.org\/10.1210\/JCEM-68-1-120","journal-title":"J Clin Endocrinol Metab"},{"key":"1442_CR95","doi-asserted-by":"publisher","DOI":"10.1007\/S11102-024-01402-2","author":"M Verrienti","year":"2024","unstructured":"Verrienti M, Marino Picciola V, Ambrosio MR, Zatelli MC (2024) Pituitary and COVID-19 vaccination: a systematic review. Pituitary. https:\/\/doi.org\/10.1007\/S11102-024-01402-2","journal-title":"Pituitary"},{"key":"1442_CR96","doi-asserted-by":"publisher","DOI":"10.1007\/S11102-024-01404-0","author":"EV Varlamov","year":"2024","unstructured":"Varlamov EV, Fleseriu M (2024) Acromegaly and COVID-19, lessons, and new opportunities. Pituitary. https:\/\/doi.org\/10.1007\/S11102-024-01404-0","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01442-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01442-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01442-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:37:59Z","timestamp":1733877479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01442-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1442"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01442-8","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"2 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An ethics statement was not required for this study type since no human or animal subjects or materials were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"AG and LdF are part of the Editorial Board of Pituitary journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}